Bid to Block GLP-1 Ads Denied; First Weekly Insulin for T2D in Kids; Fertility Fell
(MedPage Today) -- A U.S. judge rejected Novo Nordisk's request to temporarily block Eli Lilly from running advertisements claiming its weight-loss and diabetes drugs are more powerful. (Reuters via AOL) The FDA expanded the approval for insulin...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.